Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07388966 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

Study acronym: SKY-MOT3
StatusRecruiting
PhaseNot specified
SponsorSYSNAV
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Feb 2028 → Dec 2028
See other at-risk trials from SYSNAV

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Feb 2028 to Dec 2028 Show 5 more changesShow less
    • Enrollment increased: 40 → 140 participants
    • Trial sites expanded: 1 → 4 locations
    • Eligibility criteria expanded, about 45 words
    • Secondary endpoints revised (8)
    • Study title revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2026 to Feb 6, 2026
    • Secondary endpoints revised (8)
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
SYSNAV
4 trials monitored
See 1 trial at risk
The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.
Trial Details
NCT Number NCT07388966
Lead Sponsor SYSNAV
Conditions
(from sponsor)		 Achondroplasia, Hypochondroplasia
Related terms Achondroplasia, Hypochondroplasia
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov